JUNE 2014
WEEK 4
WEEK 8
Legalising medical use of cannabis
387, 399
SAMA – past, present and future Founder genes and Parkinson’s disease Children’s eyes and ears ART initiation targets CME: Sexual health in the South African context
410 th
Sou y the tion, the 411, 413 hed b ssocia , Publis
SAMF
JUNE 2014 VOL. 104 NO. 6 385-450
U N T R E AT E D
VOL. 104 NO. 6
ical A octors n Med aimed at d tists Africa g s, den lary is scribin formu cists, nurse d with the on Pre e nc a e Guida pharm rs concern ctive the st-effe es. d and o in nd co act an safe a g of medic tary Tr Alimen m ribin olis s presc g Metab dicine in -form an Me d and od ic lo fr B A and outh rche Blood The S ry is resea f the o s la rs an u e mb Org m Form by me ical r Syste written ion of Clin niversity ascula Cardiov Divis n f the U logy o collaboratio co a . icals Pharm Town, in ionals atolog e rofess Derm p of Cap re ca ealth m and with h Syste
407, 431 428
F M A S
n Af ri c a South icines Med ar y ul Fo r m
439-450
y urinar Genito es ormon Sex H al ormon mic H Syste ns tio ra r Prepa tives fo i-infec al Ant Gener se mic U Syste and s plastic Agent Antineo odulating om m Immun Syste al et loskel Muscu ystem vous S al Ner Centr
WEEK 12
asitic
Antipar
n, ociatio , al Ass Medic hing Group frican lis outh A edical Pub ds 7430 S e Th and M X1, Pinelan lth ea H e Bag Privat
ducts
Pro
m
Syste
ratory
Respi
ans
Org ensory
S
4-n-Butylresorcinol ‒ a highly effective tyrosinase inhibitor. Now in EUCERIN® EVEN BRIGHTER
ition d E h t 11
11th n Editio
y, acolog . Pharm wn Clinical of Cape To p u ion of ty is ro si iv G er D g hin the Univ ced by iences, edical Publis ssociation. Produ f Health Sc A M h and an Medical yo lt lt ea cu H Fa Afric y the hed b of the South Publis
edia
ast M
Contr
ent of
Treatm
ning
Poiso
The ESSENTIAL MEDICAL REFERENCE for every healthcare professional! The convenient pocket-sized design enables you to fit it comfortably into your hospital bag or coat pocket, so it can always be at hand for ready reference. South African Medicines Formulary (SAMF), produced by the Division of Clinical Pharmacology of the University of Cape Town, provides easy access to the latest, scientifically accurate information, including full drug profiles, clinical notes and special prescriber’s points. The thoroughly updated 11th edition of SAMF is your essential reference to the rational, cost-effective and safe use of medicines.
EUCERIN® Skin Research offers an effective and safe solution for the topical treatment of hyperpigmentation. With highly effective B-Resorcinol, clinically shown to be a superior human tyrosinase inhibitor*, NEW EUCERIN® EVEN BRIGHTER works deeper to reduce hyperpigmentation at the source. Tolerability and efficacy are clinically proven, with the first visible effects evident after just 4 weeks of use, and increasing over time. (B-Resorcinol is a synthetic organic compound, which is chemically different from resorcinol)
Please direct all order queries to: Edward – Fax: 086 600 6218 email: edwardm@hmpg.co.za Tax invoice to be posted on dispatch of order.
www.eucerin.com
*Topical treatment of hyperpigmentation. L Kolbe, T Mann, W Gerwat, J Batzer, S Ahlheit, C Scherner, H Wenck, F Stab
10013829_Even_Brighter_FP_Professional_297X210.indd 1
MEDICAL SKIN SCIENCE THAT SHOWS
2014/03/13 12:02 PM